Regeneron partners, fujifilm partners to expand the power of production

Regeneron Pharmacy entered a new production and supply agreement with Fujifilm Diosynth biotechnology to expand the capacity.

More than $ 3 billion, the partnership, in the United States, Almost Double Carolina, Holly Springs is awarded the production capacity of Double Regeneron in the United States using FUJIFILM’s new Biofarmautal.

The agreement will facilitate additional production of Regeneron’s biological drugs. Technology transmission is set up to start immediately.

According to the agreement, Fujifilm will support US-based production for more than a decade of Regeneron.

This is expected to be held on Fujifilm’s Holly Springs, and the planned operations started this year through the planned expansion.

The site is the main part of Fujifilm’s Kojox-related production network, which offers a module approach to equipment and processes to increase the transfers of the supply chain safety and technology.

The focus is further proven with a fundamental investment in the New York province, focusing on innovation and patient care.

Currently, it is expanding Tarrytown campus with about $ 3.6 billion, a $ 3.6 billion investment to prepare for 1,000 Dolu work hours and expand research and prinancial proposals.

In addition, Renselaer is being built in New York, a new filling plant / finish production facility and the acquisition of a property in the Saratoga springs increases the power of production and potential production.

The co-chair of the Board, Director General and President Leonard Schleifer said, “Our experience and clinical pipeline filled our experience and clinical pipeline with important medicines and needed further production capacity to fulfill our science.

“We need this need by growing investment in New York and North Carolina. We are proud to develop biotechnics, increase the health of people around the world, economic growth and high-paying jobs for America.”

Reveneron, New York and North Carolina, the current and planned investment in the field of infrastructure and production, he said, he was expected to exceed $ 7 billion.

“Regeneron partners, fujifilm partners were originally created and published to expand the power of production Pharmaceutical technologyA global brand.

The information on this site has only been included in the faith for general information purposes. We are not intended to give advice for you to be careful and provide no representation or intended representation or intended representation or intended. You must receive professional or specialist recommendations before any action on the basis of our site.